Pathak GN, Desai AD, Samie FH. Evaluating immune-related adverse events associated with the novel LAG3 inhibitor relatlimab in combination treatment of malignant melanoma: A retrospective comparative pharmacovigilance analysis of the FAERS database. J Am Acad Dermatol 2025 Oct 16:S0190-9622(25)03023.
PMID: 41109451